Will screening individuals at high risk of cardiovascular events deliver large benefits?

BMJ

Volumn 337, Issue 7673, 2008, Pages 784-785

  Jackson, Rod ^a   Wells, Sue ^a   Rodgers, Anthony ^a   Capewell, Simon ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CARDIAC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

EID: 53649106523     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (0)